ID: ALA4578471

Max Phase: Preclinical

Molecular Formula: C17H24FNO

Molecular Weight: 277.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(CCCCCCc1ccc(F)cc1)N1CCCC1

Standard InChI:  InChI=1S/C17H24FNO/c18-16-11-9-15(10-12-16)7-3-1-2-4-8-17(20)19-13-5-6-14-19/h9-12H,1-8,13-14H2

Standard InChI Key:  KSKZIBCRFKPPPK-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 277.38Molecular Weight (Monoisotopic): 277.1842AlogP: 3.94#Rotatable Bonds: 7
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.69Np Likeness Score: -0.90

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source